GL1X · GenesisL1 explorer

Research workbench

Structure of phosphorylated THR160 CDK2/CYCLIN a in complex with the inhibitor variolin B

Analyse Structure of phosphorylated THR160 CDK2/CYCLIN a in complex with the inhibitor… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3BHV
Type
protein
Length
1,094 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cell division protein kinase 2; Cyclin-A2
EC
2.7.11.22
UniProt
P24941, P30274
Ligands
VAR, MG
Pockets
12 · best druggability 0.81

Structure

x-ray diffraction · 3 distinct chains · 45% helix, 12% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACell division protein kinase 2 (EC 2.7.11.22)protein29834% helix, 17% strandP24941
B, DCyclin-A2protein26268% helix, 0% strandP30274
CCell division protein kinase 2 (EC 2.7.11.22)protein27235% helix, 19% strandP24941

Ligands and binding sites

  • VAR · 9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol · ligand · 2 copies · chains A, C
  • MG · Magnesium ion · metal · 2 copies · chains B, D
  • SGM · Monothioglycerol · additive · 3 copies · chains A, B, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 9 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11220.810.9924empty
21100.810.9921empty
39270.750.7888empty
43490.710.8337VAR
52370.670.8426VAR

Interfaces

5 interfaces between chains.

  • C–D · 1942 Ų buried · 37 hydrogen bonds · protein-protein
  • A–B · 1904 Ų buried · 37 hydrogen bonds · protein-protein
  • A–D · 506 Ų buried · 3 hydrogen bonds · protein-protein
  • B–C · 478 Ų buried · 2 hydrogen bonds · protein-protein
  • A–C · 94 Ų buried · 1 hydrogen bond · protein-protein

Modifications

Observed in the structure: 2 covalent, 2 modified (additive adduct, phosphorylation).

Compared structures

  • 3BHV · Structure of phosphorylated Thr160 CDK2/cyclin A in complex with the inhibitor variolin B · the same entry in another collection · chain D against D, TM-score 1.00
  • P30274 · AlphaFold monomer V2.0 prediction for cyclin-A2 (P30274) · a predicted model of the same protein · chain B against A, TM-score 0.99
  • P24941 · AlphaFold monomer V2.0 prediction for cyclin-dependent kinase 2 (P24941) · a predicted model of the same protein · chain A against A, TM-score 0.91

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.